Profile舒占永博士 Dr. James Shu
VP of Analytical Science of Abogen Biosciences Inc.
舒占永博士现任艾博生物分析科学副总裁，主要负责mRNA疫苗和药物相关的分析开发与临床产品的质量控制。加入艾博生物之前，舒博士在苏桥生物和苏州药明生物担任分析开发执行主任。2020年回国前，舒博士在美国加州大学尔湾分校和多家药企从事生物化学，和生物药相关的研究与开发工作。舒博士曾在Penn state University和中国科学院生物物理研究所从事博士后研究工作，舒博士拥有中国科学院大连化学物理研究所物理化学博士学位。
Dr. Shu Zhanyong is currently the Vice President of Analytical Science of Abogen Biosciences Inc., he is mainly responsible for the analytical development and quality control of mRNA vaccine and drug product pipelines. Before joining Abogen Biosciences, Dr. Shu served as the executive director of analytical development at CMAB and WuXi Biologics, Suzhou. Before returning to China in 2020, Dr. Shu was engaged in the research and development in the field of Biochemistry and biopharmaceuticals at the University of California, Irvine, and more biopharmaceutical companies. Dr. Shu worked as a postdoctoral researcher at Penn state University and Institute of Biophysics, Chinese Academy of Sciences. Dr. Shu holds a Ph.D. in Physical Chemistry from Dalian Institute of Chemical Physics, Chinese Academy of Sciences.